Better Coronavirus Stock: Inovio vs. Regeneron

There has been at least one group of stocks that has delivered tremendous returns so far in 2020. I'm referring to the stocks of companies that are developing drugs and vaccines targeting novel coronavirus disease COVID-19.

Two of the leaders in these efforts are Inovio Pharmaceuticals (NASDAQ: INO) and Regeneron Pharmaceuticals (NASDAQ: REGN). Shares of Inovio have skyrocketed close to 150% year to date, while Regeneron stock has jumped more than 30%. Which coronavirus-focused stock is the better pick for long-term investors? 

Image source: Getty Images.

Continue reading

Source Fool.com